BMJ  2007;334:1112-1113 (26 May), doi:10.1136/bmj.39204.531586.AD

Practice

NICE guidelines

Secondary prevention for patients after a myocardial infarction: summary of NICE guidance

¹ Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, ² National Collaborating Centre for Primary Care, Royal College of General Practitioners, London, ³ Barts and the London Queen Mary's School of Medicine and Dentistry, London

This is one of a series of BMJ summaries of new NICE guidelines, which are based on the best available evidence; they will highlight important recommendations for clinical practice, especially where uncertainty or controversy exists.

The first 150 words of the full text of this article appear below.

Why read this summary?

Although premature mortality from coronary heart disease in the United Kingdom has fallen since the 1970s, it remains higher than in most other Western countries. After an acute myocardial infarction, many eligible patients are prescribed aspirin, blockers, angiotensin converting enzyme inhibitors, and statins. Not everyone, however, is offered the most effective secondary prevention^{1 2}—that is, all four of these drugs or other effective drugs—nor does everyone receive lifestyle advice and cardiac rehabilitation. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on effective secondary prevention in patients after myocardial infarction.³ The detailed consideration of the evidence is available in the full guideline (www.nice.org.uk/CG048).

Recommendations

NICE recommendations are based on systematic reviews of best available evidence. For the guidance on secondary prevention for patients after a myocardial infarction, in cases where minimal evidence was available, the guideline development group developed the recommendations . . . [Full text of this article]

Overcoming barriers

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation

Rick Goud, Nicolette F de Keizer, Gerben ter Riet, Jeremy C Wyatt, Arie Hasman, Irene M Hellemans, and Niels Peek
BMJ 2009 338: b1440. [Abstract] [Full Text] [PDF]

We help treat acute coronary syndromes

Hasnain M Dalal
BMJ 2007 334: 1336. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Goud, R., de Keizer, N. F, ter Riet, G., Wyatt, J. C, Hasman, A., Hellemans, I. M, Peek, N. (2009). Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation. BMJ 338: b1440-b1440 [Abstract] [Full text]  
• Starfield, B, Hyde, J, Gervas, J, Heath, I (2008). The concept of prevention: a good idea gone astray?. J. Epidemiol. Community Health 62: 580-583 [Abstract] [Full text]  
• Skinner, J S, Cooper, A, Feder, G S, on behalf of the Guideline Development Group, (2007). Secondary prevention for patients following a myocardial infarction: summary of NICE guidance. Heart 93: 862-864 [Abstract] [Full text]  
• Dalal, H. M (2007). We help treat acute coronary syndromes. BMJ 334: 1336-1336 [Full text]  

Rapid Responses:

Read all Rapid Responses

more evidence is required before following NICE guidelines on coprescription of aspirin and warfarin

oscar,m jolobe, et al.
bmj.com, 25 May 2007 [Full text]

Coronary heart disease support groups can help post-MI patients to follow NICE guidance in the long-term

Lisa C Hanna, et al.
bmj.com, 29 May 2007 [Full text]

Offfering choice could improve the uptake of cardiac rehabilitation

Hasnain M Dalal, et al.
bmj.com, 1 Jun 2007 [Full text]

Screening for Cardiovascular Risk

David J Thomson, et al.
bmj.com, 13 Jul 2007 [Full text]

Online poll

Find out more here>> and here>>